Accretion Pharmaceuticals (ACCPL) Shareholding Pattern

NSE: ACCPL • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 73.52%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 22.01%
Total Shareholders 1,179
As of Dec 2025
View the latest shareholding pattern of Accretion Pharmaceuticals (ACCPL) including promoter, FII, DII, and public holdings. Track ACCPL ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See ACCPL Benjamin Graham valuation)

Accretion Pharmaceuticals (ACCPL) Shareholding Summary

  • Promoter holding remains unchanged at 73.52% in Dec 2025
  • FII/FPI holding remains unchanged at 0.00% in Dec 2025
  • DII holding remains unchanged at 0.00% in Dec 2025
  • Public holding has decreased from 22.85% to 22.01% in Dec 2025
  • Number of shareholders decreased from 1,498 to 1,179 in Dec 2025

ACCPL Quarterly Ownership Changes

Quarter-over-quarter changes for Accretion Pharmaceuticals from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
No Change
DII Holding Change
Sept 2025 to Dec 2025
No Change
Public Holding Change
Sept 2025 to Dec 2025
-0.84%

Accretion Pharmaceuticals (ACCPL) Quarterly Shareholding Trends

Visual breakdown of ACCPL ownership distribution over time. Learn more about ACCPL market capitalization.

Promoter
FII
DII
Public
Government

Rising institutional holdings in ACCPL often correlate with improved fundamentals. Check out ACCPL fundamental valuation.

Accretion Pharmaceuticals (ACCPL) Shareholding Data

Download complete ACCPL ownership data for offline analysis. Discover ACCPL 52-week high low.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 73.52% 0.00% 0.00% 0.00% 22.01% 4.47% 100.00% 1,179
Sept 2025 73.52% 0.00% 0.00% 0.00% 22.85% 3.63% 100.00% 1,498
Jun 2025 73.50% 0.00% 0.00% 0.00% 21.46% 5.04% 100.00% 1,628
May 2025 73.50% 0.00% 0.00% 0.00% 19.44% 7.06% 100.00% 8
Jan 2025 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 8
Sept 2024 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 8

ACCPL promoter holding above 50% indicates strong insider confidence. Explore the ACCPL earnings valuation for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 73.52% 0.00% 0.00% 0.00% 22.01% 4.47% 100.00% 1,179
Sept 2025 73.52% 0.00% 0.00% 0.00% 22.85% 3.63% 100.00% 1,498
Jun 2025 73.50% 0.00% 0.00% 0.00% 21.46% 5.04% 100.00% 1,628
May 2025 73.50% 0.00% 0.00% 0.00% 19.44% 7.06% 100.00% 8
Jan 2025 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 8
Sept 2024 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 8

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 73.52% 0.00% 0.00% 0.00% 22.01% 4.47% 100.00% 1,179

Year-over-year trends reveal long-term ownership shifts.

Understanding Accretion Pharmaceuticals (ACCPL) Shareholding Pattern

Accretion Pharmaceuticals shareholding pattern reveals who owns ACCPL stock and how ownership changes over time. High promoter stakes in ACCPL often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your ACCPL trades. ACCPL financial statements

Combine ACCPL ownership analysis with price movements and financial performance for a complete investment picture. (See Accretion Pharmaceuticals dividend policy)